How much funding has ZygoFix raised?

ZygoFix has raised $2.0M in total funding, most recently a Series A round.

Who are ZygoFix's investors?

ZygoFix's investors include OurCrowd, Peregrine Ventures.

Where is ZygoFix headquartered?

ZygoFix is headquartered in Israel.

What industry is ZygoFix in?

ZygoFix operates in Biotech, Healthcare.

ZygoFix

Reimagining spinal fusion.

Israel · $2.0M raised

Biotech

Healthcare

Employees: 1–10
Business Model: B2B
Website: zygofix.com

Total Funding: $2.0M
Last Round: $2.0M Series AMar 2021
Rounds: 1

About

ZygoFix is an Israeli medical device company developing zLOCK, a bendable spinal fusion implant aimed at transforming joint stabilization and fusion for surgeons and patients. The company was founded by orthopedic industry veterans, including CTO Uri Arnin — a serial spinal-implant entrepreneur holding 29 issued patents — and focuses on safe, effective, minimally invasive fixation solutions tailored to the fast-growing Ambulatory Surgery Center (ASC) market. ZygoFix is incubated by Israel's Trendlines Group and operates out of the Misgav Business Park in Israel.

Summary

ZygoFix is a Biotech company based in Israel. It has raised $2.0M in total across 1 round, most recently a $2.0M Series A round in Mar 2021. Investors include OurCrowd and Peregrine Ventures.